Related Experiment Videos

Safety profile of thrombolytic drugs

A P Maggioni¹, C Fresco

¹Department of Cardiovascular Disease, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

Arquivos Brasileiros De Cardiologia

|July 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational study.

European heart journal. Cardiovascular pharmacotherapy·2023

Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation.

International journal of cardiology·2018

Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis.

Patient preference and adherence·2016

Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.

QJM : monthly journal of the Association of Physicians·2015

Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial.

International journal of obesity (2005)·2014

Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2012

See all related articles